Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease

University of Kuopio, Kuopio, Northern Savo, Finland
Neurology (Impact Factor: 8.29). 10/2007; 69(13):1331-41. DOI: 10.1212/01.wnl.0000277292.37292.69
Source: PubMed


Functional MRI (fMRI) has shown promise as a tool to characterize altered brain function in Alzheimer disease (AD) and for use in proof of concept clinical trials. FMRI studies of subjects with AD have demonstrated altered hippocampal and neocortical activation while encoding novel stimuli compared to older controls. However, the relationship between fMRI activation and performance on standardized clinical trial memory measures has not been fully investigated.
To determine whether patterns of activation during an associative-memory fMRI paradigm correlate with performance on memory measures used in AD clinical trials.
Twenty-nine subjects with AD underwent neuropsychological testing, including the AD Assessment Scale (ADAS-Cog), and an associative-encoding fMRI paradigm. Scores were entered as regressors in SPM2 analyses of the differential fMRI activation to novel-vs-repeated (NvR) stimuli. To account for cerebral atrophy, native-space structure-function analyses were performed with subjects' high-resolution structural images.
Performance on the ADAS-Cog verbal memory component, and the ADAS-Cog total score, correlated with NvR activation in left superior temporal (p = 0.0003; r = -0.51) and left prefrontal (p = 0.00001; r = -0.63) cortices. In a subgroup with more extensive neuropsychological testing (n = 14), performance on the Free and Cued Selective Reminding Test was correlated with activation in these same regions. fMRI activation remained correlated with performance even when accounting for atrophy.
The relationship between functional MRI (fMRI) activation and standardized memory measures supports the potential use of fMRI to investigate regional mechanisms of treatment response in clinical trials of novel therapies for Alzheimer disease. .

Download full-text


Available from: Bradford Dickerson, Feb 10, 2016
  • Source
    • "Increased blood flow to specific brain regions has also been identified, including the parahippocampal gyrus and bilateral inferior frontal gyri, as well as increased connectivity (i.e., white matter) in the uncinate fasciculus and forceps minor (Aslan et al., 2012). Positive cognitive outcomes reported in these studies include face–name associative encoding (Celone et al., 2006; Diamond et al., 2007), visuospatial paired associate learning (Gould et al., 2006), abstract pattern recall (Grön, Bittner, Schmitz, Wunderlich, & Riepe, 2002), free word recall (Becker et al., 1996), attenuated decline (Mini-Mental State Exam [MMSE] and Alzheimer's Disease Assessment Scale-cog), and word recall for patients with MCI (Belleville et al., 2011; Forster et al., 2011). Specific to individuals with MCI, a systematic review of 20 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current review addresses the need for increased use of evidence-based, nonpharmacological therapies for individuals with dementia. To facilitate understanding of the potential efficacy of nonpharmacological therapies on cognitive functioning for individuals with dementia, the mechanisms of action for selected therapies are described, including the assessment method used to identify the mechanism. The strength of evidence supporting each therapy was evaluated, with some therapies demonstrating strong support and others only moderate support for their effectiveness and mechanism of action. Therapies with the strongest support include (a) cognitive training/stimulation, (b) physical exercise, and (c) music. Therapies with moderate support include (a) biofield, (b) meditation, (c) engagement with a naturally restorative environment, and (d) social engagement. Although the strength of evidence varies, together these therapies offer treatments designed to improve cognitive functioning, have low risks and adverse effects, and have the potential for widespread accessibility, thereby increasing the potential range of therapies for individuals with dementia. [Res Gerontol Nurs. 20XX; X(XX):XX-XX.]. Copyright 2015, SLACK Incorporated.
    Full-text · Article · May 2015 · Research in Gerontological Nursing
  • Source
    • "Functional brain imaging is increasingly being applied to investigate brain function in clinical populations (e.g. Diamond et al., 2007; Karmonik et al., 2010; O'brien et al., 2010; Sundermann et al., 2014), it is important to be able to conduct a detailed exploration of the impact of brain diseases upon neuroimaging signals and their relationship to neuronal activity in animal models. This includes the use of both transgenic lines and pharmacologically or surgically induced disease states (Sanganahalli et al., 2013; Serres et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many of the major advances in our understanding of how functional brain imaging signals relate to neuronal activity over the previous two decades have arisen from physiological research studies involving experimental animal models. This approach has been successful partly because it provides opportunities to measure both the hemodynamic changes that underpin many human functional brain imaging techniques and the neuronal activity about which we wish to make inferences. Although research into the coupling of neuronal and hemodynamic responses using animal models has provided a general validation of the correspondence of neuroimaging signals to specific types of neuronal activity, it is also highlighting the key complexities and uncertainties in estimating neural signals from hemodynamic markers. This review will detail how research in animal models is contributing to our rapidly evolving understanding of what human neuroimaging techniques tell us about neuronal activity. It will highlight emerging issues in the interpretation of neuroimaging data that arise from in vivo research studies, for example spatial and temporal constraints to neuroimaging signal interpretation, or the effects of disease and modulatory neurotransmitters upon neurovascular coupling. We will also give critical consideration to the limitations and possible complexities of translating data acquired in the typical animals models used in this area to the arena of human fMRI. These include the commonplace use of anesthesia in animal research studies and the fact that many neuropsychological questions that are being actively explored in humans have limited homologs within current animal models for neuroimaging research. Finally we will highlighting approaches, both in experimental animals models (e.g. imaging in conscious, behaving animals) and human studies (e.g. combined fMRI-EEG), that mitigate against these challenges.
    Full-text · Article · Aug 2014 · Frontiers in Neuroscience
  • Source
    • "Its use in both in clinical practice and in clinical trials has increased recently due, in part, to accumulating data demonstrating its association with CSF biomarkers (Rami et al., 2011; Wagner et al., 2012), neuroimaging findings (Koric et al., 2013; Petersen et al., 2000; Sarazin et al., 2010; Zimmerman et al., 2008), functional imaging (Diamond et al., 2007; Lekeu et al., 2003; McLaren et al., 2012), and autopsy-markers of AD (Grober et al., 1999). Performance on the test defines the core clinical phenotype in the revised criteria for prodromal AD (Dubois et al., 2007, 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose was to compare the Spanish language picture version of the Free and Cued Selective Reminding Test with Immediate Recall (pFCSRT+IR) and the Mini Mental State Exam (MMSE) in identifying very mild dementia among Spanish speaking Latino patients. The tests and an independent diagnostic assessment were administered to 112 Latino patients free of medically diagnosed dementia from an urban primary care clinic. Receiver operating characteristic (ROC) curves and the area under the curve (AUC) were used to examine differences in the operating characteristics of the pFCSRT+IR and the MMSE. Cut scores were manipulated to equate sensitivities (specificities) at clinically relevant values to compare differences in specificities (sensitivities) using the Pearson Chi Square test. Youden's index was used to select the optimal cut scores. Twenty-four of the 112 primary care patients (21%) received a research dementia diagnosis, indicating a substantial burden of unrecognized dementia. MMSE scores but not free recall scores were associated with years of education in patients free of dementia. AUC was significantly higher for free recall than for MMSE. Free recall performed significantly better than the MMSE in sensitivity and in specificity. Using optimal cut scores, patients with impaired free recall were 10 times more likely to have dementia than patients with intact recall, and patients with impaired MMSE scores were 4.5 times more likely to have dementia than patients with intact scores. These results suggest that the Spanish language pFCSRT+IR may be an effective tool for dementia screening in educationally diverse Latino primary care populations. (JINS, 2014, 20, 1-8).
    Full-text · Article · Aug 2014 · Journal of the International Neuropsychological Society
Show more